Everything below concerns reference standard. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-22. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water; stock solutions use organic solvent. |
| Storage | -20°C, desiccated, protected from light | Limits hydrolysis and photodegradation. |
| Analytical method | HPLC-UV/MS | Used for identity and purity assessment. |
| Synonyms | SR9009, Stenabolic | Naming varies by supplier. |
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
==== Switzerland ==== In Switzerland cider is called Suure Most or Saft in the German-speaking part, Cidre in the Romandy, and sidro in the Italian-speaking regions. The drink was made popular in the 19th century when apple production increased due to progress in pomology. At the turn of the century, cider consumption was at 28.1 litres per person. In the 1920s, advantages in the pasteurisation of apple juice and the emerging temperance movement led to a strong decrease of cider production. Today, typical Swiss cider consists of fermented apple juice mixed with 30% fresh juice which is added for sweetness. This drink is then pasteurised and force-carbonated. Imported cider is not common as according to Swiss laws cider must contain more than 70% of juice.
With the new season of the J.League commencing in March 1995, Wenger set about assembling his squad and backroom staff. He hired former Valenciennes manager Boro Primorac, whom he had befriended during the match-fixing scandal, as his assistant. Alexandre Torres joined Nagoya after Wenger identified the defender by watching Brazilian football on the television, and the manager brought in Franck Durix and his former player Passi. Nagoya finished bottom of the J.League the season before Wenger's arrival, and continued their poor form into the following campaign, losing several matches in a row. In response to the situation, Wenger altered his managerial style, becoming less amicable with his players and openly questioning their desire. To boost morale, he took his squad to Versailles for their mid-season break, where they went through a rigorous, but creative, training regime. Players were expected to make decisions for themselves on the pitch, instead of relying on the manager; Wenger was reported to have shouted to his players "Don't look at me to ask me what to do with the ball!" and "Decide for yourself! Why don't you think it out?" One player who greatly benefited from Wenger's guidance was Dragan Stojković, a midfielder whose disciplinary record improved considerably. Wenger's methods had the desired effect – Nagoya won 17 of their following 27 games to finish runners-up in 1995. He shortly received the J. League Manager of the Year award for 1995, while Stojković claimed the player's honour.
== Government == Since 1945, the most senior state official in Serbia, and thus de facto head of state, was President of the People's Assembly of Serbia, who also presided over the collective Presidency of the People's Assembly (1945–1953), and Presidency of the Assembly (1953–1990). In 1974, new Constitution of Serbia was adopted, and collective state presidency was formed, not as a committee of the Assembly, but as a supreme governing body. Since then, President of the Presidency served as the most senior state official of the Socialist Republic of Serbia. At first, President was elected for 4 years mandate, but in 1982 it was lowered to 2 years. Main executive body, since 1945, was the People's Government of Serbia. In 1953, it was renamed as the Executive Council of Serbia. It served as the executive branch of the People's Assembly. The president of the Executive Council had a role of prime minister.
Sources: en.wikipedia.org
The climate of mainland Portugal and Madeira, together with their surrounding waters, is Mediterranean, whereas the Azores and its adjacent waters mainly have a temperate oceanic climate. Portugal's terrain has a diverse variety of regional climates for its size. The average temperature in Portugal varies from 4–20 °C (39.2–68.0 °F) in the mainland, around 18 °C (64.4 °F) in the Azores, and 9–19 °C (48.2–66.2 °F) in Madeira. The Iberian Peninsula is located at the southern margin of the temperate zone and at the northern margin of the subtropical high-pressure zone. Additionally, Portugal's climate is influenced by the seasonal latitudinal shift of the jet stream, which directly impacts the trajectory of the polar front. Typically in the winter, the jet stream moves southwards and Portugal comes under the influence of the polar front, producing colder temperatures. When the polar front moves northward, Portugal comes under the influence of the Azores High bringing atmospheric stability during the summer. Upwelling occurs at the coast creating the Nortada, a summer wind along the coast. Wildfires are a serious challenge in Portugal, with nearly 30% of those recorded in 2024 having an undetermined origin and arson accounting for almost five-sixths of the total burned area. Between 2014 and 2024, Portugal recorded an annual average of 12,496 fires and 112,455 ha (434 sq mi) burned, making it the European Union country with both the highest average number of wildfires and the greatest average burned area over that period.
=== Solvent/detergent (S/D) inactivation === This process, developed by the New York Blood Center, is the most widely used viral inactivation method to date. It is predominantly used in the blood plasma industry, by over 50 organizations worldwide and by the American Red Cross. This process is only effective for viruses enveloped in a lipid coat, however. The detergents used in this method interrupt the interactions between the molecules in the virus's lipid coating. Most enveloped viruses cannot exist without their lipid coating so are destroyed when exposed to these detergents. Other viruses may not be destroyed but they are unable to reproduce rendering them non-infective. The solvent creates an environment in which the aggregation reaction between the lipid coat and the detergent happen more rapidly. The detergent typically used is Triton X-100. This process has many of the advantages of the "traditional" removal techniques. This process does not denature proteins, because the detergents only affect lipids and lipid derivatives. There is a 100% viral death achieved by this process and the equipment is relatively simple and easy to use. Equipment designed to purify post-virus inactivated material would be necessary to guard against contamination of subsequent process streams. S/D treatment utilizes readily available and relatively inexpensive reagents, but these reagents must be removed from the product prior to distribution which would require extra process steps.
The first clinical study of vosilasarm, a small (n=22) phase 1 study in women with metastatic breast cancer, was started in 2017 and completed in 2020, with results published in 2019, 2020, and 2022. As of March 2023, vosilasarm is in phase 1/2 clinical trials for the treatment of breast cancer. Aside from its development as a potential pharmaceutical drug, vosilasarm is on the World Anti-Doping Agency list of prohibited substances and is sold for physique- and performance-enhancing purposes by black-market Internet suppliers. Vosilasarm is often used in these contexts at doses that have not been evaluated in clinical trials, with unknown effectiveness and safety. Many products sold online that are purported to be a specific SARM either contain none or contain other unrelated substances. Social media has played an important role in facilitating the widespread non-medical use of SARMs.
3-phosphoglycerate can be separated and measured using paper chromatography as well as with column chromatography and other chromatographic separation methods. It can be identified using both gas-chromatography and liquid-chromatography mass spectrometry and has been optimized for evaluation using tandem MS techniques. 2-Phosphoglyceric acid Calvin-Benson cycle Photosynthesis Ribulose 1,5-bisphosphate
Sources: en.wikipedia.org
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.
The solid is generally kept cold, dry, and protected from light. Solutions are often frozen in single-use aliquots to reduce repeated freeze-thaw cycles.
It indicates a material sold for laboratory study, not for human use. The label does not guarantee pharmaceutical purity, sterility, or regulatory approval.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.